Galmed Pharmaceuticals Ltd. (GLMD) Declined -5.5% or -0.65 To Price $11.16 On Tuesday


Galmed Pharmaceuticals Ltd. (GLMD) declined -5.5% or -0.65 to $11.16. It is nearly 337945 shares traded, which is 50.36% compare to the average total volume 671123. The market cap of GLMD is $233.39 million. The year to date change is 20.27%. The 52 week price range is from $3.61 to $27.06. Price of GLMD have changed -9.92% during last week. It have changed -22.51% over last month, 101.54% over last 3 months, 24.84% over last 6 months and 40.60% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GLMD is 12.81. It is 14.78% above current price. The 200-day Moving Averages for GLMD is 8.83. It is -20.88% below current price. The 52-week High is 27.06. It is 142.47% from the current price. The 52-week Low is 3.61. It is -67.65% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GLMD is 0.72 on 2018-07-31. Short % to float is 3.06%. There are some statistics of GLMD. It is has market cap $233.39 million. The share outstanding is 20.91 million. The average volume is 671123. The revenue is 273000. The percent of top 15 Institution holding is 21.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GLMD is -23.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GLMD is -22.19%.


Tags:

Share this post